• Family Update Newsletter

    Family Update is a biweekly newsletter we hope families visiting the Cancer and Blood Diseases Institute can use. This newsletter is our opportunity to share with you stories about the exciting work of our cancer scientists, advances in medical care, and our heroes and supporters. Family Update also contains information about upcoming community events, as well as events and activities here at the hospital for our patients, their families and friends. You can also find out who the current fellows and attending physicians are.

    Cover Story From the Most Recent Issue

    Denise Adams Receives $1.6 Million Grant to Study Promising New Treatment Strategy for RDenise Adams, MD.are Cancer

    The U.S. Food and Drug Administration (FDA) recently awarded Cancer and Blood Diseases Institute physician Denise Adams $1.6 Million to study a new approach to treating a rare cancer.

    High Risk Kaposiform Hemangioendothelioma (KHE) is a life-threatening disease that usually occurs in very young infants. There are currently only limited treatment options and they have not been as successful as desired. Dr. Adams has done preliminary research on treating KHE with a drug called Vincristine with greatly improved quality of life and outcomes.

    With the FDA funding, Dr. Adams will be able to conduct more thorough research. This research will confirm the most effective treatment for KHE, either Sirolimus or Vincristine, and will help pave the way to getting the most effective treatment to patients.

    The company Pfizer has donated expensive medication and additional funding for the research. Dr. Adams, a member of the Division of Oncology and Medical Director of the Hemangioma and Vascular Malformation Program, is grateful to the FDA and Pfizer for this opportunity to help find a cure for KHE.

    Read Complete Issue

    Read our most recent issue, published in portable document format (PDF). 

    Recent Past Issues

  • Support Services

    The Family Support Network at Cincinnati Children’s supports the quality of life for children and families experiencing cancer, a blood disease or immune disorder.

    Read More